Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)
Clinical trial NCT03406715 · TERMINATED
Trial details
- NCT number
- NCT03406715
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2022-03-23
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.